Awards and recognitions

Below are some of the accolades we received for our contributions to corporate citizenship.

• Most Admired Pharmaceutical Company, Novartis no. 1, Med Ad News, November 2009
• Dow Jones Sustainability Index, Novartis named Sustainability Leader, DJSI, September 2009
• 2009 European Inventor of the Year award (in the "Non-European" category) to Professor Yiqing Zhou and his team at the Microbiology and Epidemiology Institute in Beijing for developing Coartem (artemether 20 mg/lumefantrine 120 mg) against malaria, European Patent Office and the European Commission’s DG Enterprise and Industry, April 2009
• World’s Most admired Companies, Novartis no. 2, Fortune magazine, March 2009
• Novartis listed in FTSE4Good Index, FTSE, May 2009
• 2009 World’s Most Ethical Companies, Novartis among top four biotech and pharma companies, Ethisphere, April 2009
• Good Company list, Novartis no.10, Manager Magazin, April 2009
• Novartis awarded “Gold Class" distinction, Sustainability Asset Management (SAM), January 2009
• Arogya Pariva awarded "Best long-term rural marketing initiative", Novartis India , Rural Marketing Association of India (RMAI), December 2008
• China Charity Award, Novartis no. 1 in the category of “Most Caring Foreign-Invested Enterprises”, Chinese Ministry of Civil Affairs, December 2008
• Novartis Chairman and CEO named “Executive of the Year”, 2008 Scrip Awards, December 2008
• Novartis Mexico awarded with the 2008 Ethics and Values in Industry awards, Confederation of Industrial Chambers, Mexico (CONCAMIN), December 2008
• Brazil’s most admired pharmaceutical company in 2008, Novartis no. 1, Carta Capital magazine, November 2008
• Novartis recognized among 2008 100 Best Companies for Working Mothers, Working Mother, October 2008
• 2008 Carbon Disclosure Project Award, September 2008
• 2008 world's most respected companies, Novartis no. 20, Barron's, September 2008
• Dow Jones Sustainability Index, Super Sector Leader in Healthcare, DJSI, September 2008
• Best places to work in industry, Novartis US no. 8, The Scientist, June 2008
• Access to medicines Index, Novartis no. 4, Innovest, June 2008
• 2008 World’s Most Ethical Companies, top four, Ethisphere, June 2008
• 2008 Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria, Novartis Italy awarded with the Business Excellence Award for its Tigray Malaria Project, June 2008
• Most admired pharmaceutical company, Novartis no. 2, “World’s most admired companies”, Fortune magazine, April 2008
• Empresa Socialmente Responsable (Socially Responsible Corporation) award, Novartis Mexico no. 1, Mexican Philanthropy Center (CEMEFI) and Mexico's Socially Responsible Corporation Alliance (AliaRSE), April 2008
• Corporate citizenship in Japan, Novartis no. 39 (out of 1 900 surveyed companies in 23 countries), Newsweek Japan, March 2008
• 2007 best employer in China, Novartis China no. 1, China Central Television (CCTV), February 2008
• Novartis awarded "Gold Class" Distinction, Sustainability Asset Management, January 2008
• 2008 great place to work, Novartis Pharma Italy among the top 35 companies to work for in Italy, Great Place to Work Institute, January 2008
• 2007 World's Most Ethical Companies, top three, Ethisphere, May 2007
• Best places to work in industry, Novartis US no. 2, The Scientist, April 2007
• Most admired pharmaceutical company, 'World's most admired companies', Fortune, March 2007
• Most socially responsible enterprise, Novartis China, 2006 China Enterprises' Corporate Social Responsibility survey, China Central TV Station (CCTV) and the Institute for Civilian Economic Research at Peking University, December 2006
• Best CSR program, SCRIP Awards, November 2006
• Top sustainability performer, Novartis #4 out of 44 pharmaceutical companies, with an AAA score, 2006 Global pharmaceutical sector report, Innovest, November 2006
• Top 100 family-friendly companies, Novartis US, Working Mother, September 2006
• World's 100 Most Respected Companies, Novartis #2 in healthcare sector and #23 across all industries, Barron, September 2006
• Inclusion in FTSE4Good Index, September 2006
• Healthcare Sector Leader, Dow Jones Sustainability Index, September 2006
• Best Corporate Citizens 2006, Novartis Taiwan, Common Wealth Magazine, June 2006
• Best places to work in industry, Novartis US #6, The Scientist, April 2006
• World's most admired companies, Novartis #47, Fortune Magazine, March 2006
• Global 100 most sustainable corporations in the world, Corporate Knights and Innovest Strategic Value Advisors, January 2006
• Business Ethics Prize 2006, German Business Ethics Network, December 2006

 

Back to top